Monoamine Oxidase Inhibitors in Neurological Diseases: 1st Edition (Hardback) book cover

Monoamine Oxidase Inhibitors in Neurological Diseases

1st Edition

By Lieberman

CRC Press

400 pages

Purchasing Options:$ = USD
Hardback: 9780824790820
pub: 1994-01-12
Currently out of stock

FREE Standard Shipping!


Emphasizing the role of monoamine oxidase (MAO) in the etiology and pathogenesis of Parkinson's disease and Alzheimer's disease, this up-to-date reference describes the genetics, physiology, biochemistry, pharmacology, and clinical aspects of this very important class of enzymes.

Details how the interaction between selegiline (deprenyl) and MAO may retard the progression of neurodegenerative disorders!

Providing the latest theories on how selegiline operates, Monoamine Oxidase Inhibitors in Neurological Diseases

  • presents fundamental information on MAO types A and B

  • examines the distribution of MAO A and B in the normal human brain

  • investigates the effects of disease and aging on MAO A and B

  • analyzes a critical role for MAO in the toxic action in Parkinson's disease

  • elucidates selegiline's novel ability to delay the progression or repair the damage of dopaminergic neurons

  • discusses the usefulness of MAO inhibitors in psychiatric disease

  • and more!
  • Reviews


    This book represents a good review of this subject.

    "-Neurological Research

    Table of Contents

    The Distribution of Monoamine Oxidases A and B in Normal Human Brain, Karin N. Westlund

    Effects of Disease and Aging on Monoamine Oxidases A and B, Manfred Gerlach, Peter Riederer, and Moussa B. H. Youdim

    Biochemistry and Mechanism of Action of Monoamine Oxidases A and B, Eimear M. O'Brien and Keith F. Tipton

    The Structure, Gene, and Promoter Organization of Monoamine Oxidases A and B, Jean Chen Shih, Kevin Chen, Joseph S. Grimsby, Qin-Shi Zhu, and Timothy K. Gallaher

    Molecular Genetics and Inheritance of Human Monoamine Oxidases A and B, Xandra O. Breakefield, Zheng-Yi Chen, Elizabeth Tivol, Christo Shalish, and Ian W. Craig

    Role of Monoamine Oxidase Genetics in the Etiology of Parkinson's Disease, Janice H. Kurth and Matthias C. Kurth

    Multiple Forms of Monoamine Oxidase and Iron: Their Relevance to the Pathology and Treatment of Parkinson's Disease, Moussa B. H. Youdim, Dorit Ben-Shachar, and Peter Riederer

    A Critical Role for Monoamine Oxidase in Toxin Action in Parkinson's Disease, Peter Jenner

    Effects of Monoamine Oxidase B Inhibitors on Dopaminergic Function: Role of 2-Phenylethylamine and Aromatic L-Amino Acid Decarboxylase, Augusto V. Juorio, Xin-Min Li, I. A. Paterson, and Alan A. Boulton

    Inhibition of Monoamine Oxidase B and the Neuroprotective Effects of Selegiline, Kevin T. Finnegan

    Reduction of Nerve Cell Death by Deprenyl Without Monoamine Oxidase Inhibition, William G. Tatton, Nadine A. Seniuk, William Y. H. Ju, and Karen S. Ansari

    Monoamine Oxidase Inhibitors as Neuroprotective Therapy, Warren Olanow and Donald B. Calne

    Selegiline as Symptomatic Treatment for Parkinson's Disease, Abraham Lieberman

    Monoamine Oxidase Inhibitors in Alzheimer's Disease, Jody Corey-Bloom and Leon J. Thal

    Role of Monoamine Oxidase Inhibitors in Psychiatry, David J. Houlihan and Samuel Gershon

    About the Series

    Neurological Disease and Therapy

    Learn more…

    Subject Categories

    BISAC Subject Codes/Headings:
    MEDICAL / General
    MEDICAL / Biochemistry
    MEDICAL / Neurology